日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Applying REWIND cardiovascular disease criteria to SUSTAIN 6 and PIONEER 6: An exploratory analysis of cardiovascular outcomes with semaglutide

将 REWIND 心血管疾病标准应用于 SUSTAIN 6 和 PIONEER 6 研究：索玛鲁肽治疗心血管结局的探索性分析

期刊:Diabetes Obesity & Metabolism
影响因子:5.7
doi:10.1111/dom.14360
Verma, Subodh; Fainberg, Udi; Husain, Mansoor; Rasmussen, Søren; Rydén, Lars; Ripa, Maria Sejersten; Buse, John B
心血管疾病
心血管
发表日期：2021
文献求助 收藏

The effect of glucagon-like peptide-1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across baseline blood pressure categories: Analysis of the LEADER and SUSTAIN 6 trials

胰高血糖素样肽-1受体激动剂利拉鲁肽和索玛鲁肽对不同基线血压类别患者心血管和肾脏结局的影响：LEADER和SUSTAIN 6试验分析

期刊:Diabetes Obesity & Metabolism
影响因子:5.7
doi:10.1111/dom.14079
Leiter, Lawrence A; Bain, Stephen C; Bhatt, Deepak L; Buse, John B; Mazer, C David; Pratley, Richard E; Rasmussen, Søren; Ripa, Maria Sejersten; Vrazic, Hrvoje; Verma, Subodh
信号转导
发表日期：2020
文献求助 收藏

The significance of ST-elevation in aVL in anterolateral myocardial infarction: An assessment by cardiac magnetic resonance imaging

前侧壁心肌梗死中aVL段ST段抬高的意义：心脏磁共振成像评估

期刊:Annals of Noninvasive Electrocardiology
影响因子:1
doi:10.1111/anec.12580
Allencherril, Joseph; Fakhri, Yama; Engblom, Henrik; Heiberg, Einar; Carlsson, Marcus; Dubois-Rande, Jean-Luc; Halvorsen, Sigrun; Hall, Trygve S; Larsen, Alf-Inge; Jensen, Svend Eggert; Arheden, Hakan; Atar, Dan; Clemmensen, Peter; Ripa, Maria Sejersten; Birnbaum, Yochai
心血管
心肌梗塞
发表日期：2018
文献求助 收藏